Glucocorticoid Therapy and Miglitol Ameliorate Reactive Hypoglycemia Secondary to Late Dumping Syndrome
Abstract
We report a case in which low-dose prednisolone (LD-PSL) and an absorbable α-glucosidase inhibitor (miglitol) effectively treated reactive hypoglycemia caused by late dumping syndrome. A 73-year-old man underwent gastric tube reconstruction after an esophagectomy for esophageal cancer. Frequent diet management and a non-absorbable α-glucosidase inhibitor (voglibose) were prescribed to treat the reactive hypoglycemia caused by late dumping syndrome; however, hypoglycemia persisted. Changing the treatment to LD-PSL and miglitol ameliorated the reactive hypoglycemia and led to a resolution of hypoglycemic symptoms. Treatment with LD-PSL and miglitol is an effective treatment option for late dumping syndrome which does not respond to either guideline-based dietary modifications or voglibose treatment.
Related
- A Novel Bioactive Component, Efoba, From Aged Garlic Targets CTSC to Suppress NET-Driven Neuroinflammation and Ameliorate Secondary Brain Injury After Intracerebral Hemorrhage.
- Parent Anxiety and Response to a Telehealth Intervention for Hypoglycemia Fear: Secondary Analysis of a Randomized Trial
- Ghrelin responses to oral glucose and reactive hypoglycemia across BMI categories
- Hypoinsulinemic hypoglycemia with hemihypertrophy in a Filipino infant: management in a resource-limited setting
- Transforming Inpatient Glycemic Management: A System-Wide Approach to Reducing Hyperglycemia and Hypoglycemia
BibTeX
@article{saito2026glucocorticoid,
title = {{Glucocorticoid Therapy and Miglitol Ameliorate Reactive Hypoglycemia Secondary to Late Dumping Syndrome}},
author = {Manabu Saito and Hiroshi Uchino and Arisa Yoshida and Genki Sato and Takahisa Hirose},
journal = {Internal Medicine},
year = {2026},
month = oct,
doi = {10.2169/internalmedicine.6534-25},
url = {https://www.jstage.jst.go.jp/article/internalmedicine/65/19/65_6534-25/_article},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Glucocorticoid Therapy and Miglitol Ameliorate Reactive Hypoglycemia Secondary to Late Dumping Syndrome
AU - Manabu Saito
AU - Hiroshi Uchino
AU - Arisa Yoshida
AU - Genki Sato
AU - Takahisa Hirose
PY - 2026
DA - 2026/10/01
JO - Internal Medicine
DO - 10.2169/internalmedicine.6534-25
UR - https://www.jstage.jst.go.jp/article/internalmedicine/65/19/65_6534-25/_article
AB - We report a case in which low-dose prednisolone (LD-PSL) and an absorbable α-glucosidase inhibitor (miglitol) effectively treated reactive hypoglycemia caused by late dumping syndrome. A 73-year-old man underwent gastric tube reconstruction after an esophagectomy for esophageal cancer. Frequent diet management and a non-absorbable α-glucosidase inhibitor (voglibose) were prescribed to treat the reactive hypoglycemia caused by late dumping syndrome; however, hypoglycemia persisted. Changing the treatment to LD-PSL and miglitol ameliorated the reactive hypoglycemia and led to a resolution of hypoglycemic symptoms. Treatment with LD-PSL and miglitol is an effective treatment option for late dumping syndrome which does not respond to either guideline-based dietary modifications or voglibose treatment.
SN - 1349-7235
SN - 0918-2918
ER -